Drug manufacturers saw their stock prices fall on Friday after vaccine skeptic Robert F. Kennedy Jr. was announced as Trump's ...
Shares of prominent vaccine makers plunged Thursday after President-elect Donald Trump announced his pick of Robert F.
Centessa had recently conducted an interim analysis of a phase 2 study of its drug, called SerpinPC, which is designed to ...
The social campaign aimed to defy stigma, give voice to patients and care providers and pave the way for the launch of a ...
Despite that underperformance over the past 2 months, I believe Pfizer stock still deserves its "Buy" rating. In my opinion, the company is likely to exceed the third-quarter 2024 consensus ...
Pfizer PFE will report its third-quarter 2024 earnings on Oct. 29, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $15.19 billion and 64 cents per share ...
Yet, despite three options on the market from Pfizer, GSK and Moderna, uptake has been slow so far this season. In a note to clients earlier this month, Jefferies analyst Michael Yee noted how ...
Oct 22 (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Pfizer's (PFE.N), opens new tab RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in ...
Pfizer has told 75 employees in Sanford, North Carolina, that their positions have been eliminated. The layoffs come three months after the company axed 150 positions in Sanford following a high ...
NEW YORK, Oct 22 (Reuters) - Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's (PFE.N), opens new tab board needs to hold management accountable ...
Investment firm Starboard Value, which has launched an activist campaign against Pfizer (NYSE:PFE), upped the ante on the New York-based pharma giant on Tuesday, noting that the company has ...
Activist hedge fund manager Jeff Smith outlined his concerns about drugmaker Pfizer on Tuesday but stopped short of offering a solution — saying that's a job for the board of directors.